2013年 学会発表・その他(海外) Symposiums/Etc.(International)
日時/Date | 学会/Symposium | 演者/Speaker | 演題/Title | 場所/Place |
2013.5 | World Congress of Nephrology | Rafiq K, Nishiyama A. | Azelnidipine enhances protective effects of olmesartan against bbb and renal injuries in type 2 diabetic mice, independent of blood pressure changes. | Hong Kong |
Morita T, Nakano D, Kitada K, Nishiyama A. | Renal iron accumulation in type 1 diabetic mice is independent of cell senescence. | |||
Hitomi H,Kobori H, Nishiyama A. | Effects of olmesartan on albuminuria and urinary angiotensinogen excretion in patients with metabolic syndrome. | |||
2013.9 | International Conference on Endothelin | Nakano D, Emoto N, Nakayama K, Yanagisawa M, Nishiyama A | Endothelial Cell-Derived ET-1 Contributes to the Severity of Septic Kidney Injury | Tokyo |
2013.9 | High Blood Pressure Research Conference | Mizushige T, Kobori H, Nishijima Y, Yano Y, Sakata K, Hayakawa M, Nishiyama A | Urinary Angiotensinogen Could be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes | New Orleans,LA |
Nishijima Y, Kobori H, Mizushige T, Hara T, Nishiyama A, Kohno M | Circadian Rhythm of Plasma and Urinary Angiotensinogen in Patients with Chronic Kidney Disease | |||
Nishioka S, Nakano D, Kitada K, Ohsaki H, Sofue T, Kohno M, Nishiyama A | P21 is Essential for the Beneficical Effects of Renal Ischemic Preconditioning in Ischemic Acute Kidney Injury | |||
Nakano D, Morita T, Kitada K, Nishiyama A | An Iron Chelator, Deferasirox, Prevents Renal Iron Accumulation and Macrophage Infiltration But Not Cell Senescence inType 1 Diabetic Mice | |||
Shibayama Y, Urushihara M, Nishiyama A, Kobori H | AngiotensinⅡ Promotes Proliferation and Fibrosis in Parietal Epithelial Cells Contributing to the Development of Crescentic Glomerulonephritis | |||
Takenaka T, Inoue T, Ohno Y, Miyazaki T, Nishiyama A, Ishii N, Suzuki H | Combined Treatment With Irbesartan and Vitamin D Retards Renal Injury in Salt-loaded Uni-nephrectomized Stroke-prone Spontaneously Hypertensive Rats | |||
Lee AY, Rodrigez RR, Martinez B, Nakano D, Nishiyama A, Ortiz R | Angiotensin Receptor Activation Contributes to Glucose Intolerance and Increased Insulin Resistance Independent of Elevated Systolic Blood Pressure Adiposity and Dyslipidemia in a Model of Metabolic Syndrome | |||
Rodriguez R, Lee A, Moreno M, Vazquez G, Ruilova SD, Nishiyama A, Ortiz RM | Angiotensin Receptor Blockade Ameliorates the Hypertension Associated with Acute Glucagon-like Peptide-1 Receptor Activation | |||
Nishiyama A. | Intrarenal vs. systemic Angiotensin Regulation |
|||
2013.11 | Annual Meetings of the American Society of Nephrology | Rafiq K, Fujisawa Y, Asadur R, Sufin A, Nakano D, Nishiyama A | Suppression of insulin resistance by renal sympathetic denervation in obese rats. | Atlanta,GA |
American Heart Association Scientific Session. | Nishiyama A | Incretin Hormones in CVD; Overview | Dallas,TX | |
2013.6 | CLINICAL AND BIOMEDICAL SPECTROSCOPY AND IMAGING III 8798 | Shun Sato, Masaru Fujiwara, Pradeep K. W. Abeygunawardhana, Satoru Suzuki, Akira Nishiyama, Ichiro Ishimaru | Proposal of One-Shot-type Spectroscopic-Tomography for Non-invasive Medical-measurement. | --- |